💊 Open Marketplace for BioPharma Research
Molecule - bringing consumer choice to biopharma
Today's Highlights
- Molecule - creating a medical future for everyone
- Blockchain jobs - a listing of fresh jobs related to web3/blockchain/crypto.
- In Other News - a few interesting developments we're tracking.
Molecule - creating a medical future for everyone
Molecule is trying to build a world where patients directly fund researchers developing the next therapeutic breakthrough they need. One where drug development is collaborative, open, and decentralized — an open bazaar where anyone with the right intentions can join. A system that could radically increase the diversity of treatments, and lower costs and time to market.
The majority of promising early-stage therapeutic research lacks funding and access. Funders struggle to discover and engage with suitable projects. Biopharma is a system with zero consumer choice and 100% dependency. To address these challenges, Molecule has set out to create an open marketplace that makes novel therapeutic projects discoverable, universally fundable and distributes ownership to patient collectives. They believe this system will be equally beneficial to the current pharma industry as it will be for patients: by decentralizing access and helping discover promising research more quickly.
The first objective on their journey is to accelerate the discovery of promising early-stage therapeutics. This is achieved by creating a platform for individuals and organizations to interact with intellectual property and data. Researchers can make their biopharma assets visible to a global audience, receive feedback and engage with potential funders. The platform allows them to list the details of their projects, specify the commercial opportunity and upload data assets. Inclined investors can discover and follow projects in areas of their interest, engage with the research team and ask for further qualification. When interest from potential investors reaches a certain maturity, the IP moves into a new licensing platform built on Web3.0.
As Linux did for open software, Molecule is on a mission to enable open, collaborative biopharma research by the people, for the people. Paul Kolhaas is the co-founder and CEO of Molecule. Molecule has raised a total of $13M in funding.
💡 Blockchain Jobs
|
ICODA
|
MELD
|
|
Coinshift
|
Toptal
|
In Other News
Ian Allison
Jesse Coghlan
William Suberg